CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro
- 21 June 2003
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 108 (3) , 234-240
- https://doi.org/10.1016/s1521-6616(03)00147-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Concordance between the CC Chemokine Receptor 5 Genetic Determinants That Alter Risks of Transmission and Disease Progression in Children Exposed Perinatally to Human Immunodeficiency VirusThe Journal of Infectious Diseases, 2001
- Polymorphisms in the CCR5 Promoter Region Influence Disease Progression in Perinatally Human Immunodeficiency Virus Type 1–Infected ChildrenThe Journal of Infectious Diseases, 2001
- Characterization of High-Risk HIV-1 Seronegative HemophiliacsClinical Immunology, 2001
- CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressorsAIDS, 2000
- CCR5 promoter polymorphism and HIV-1 disease progressionThe Lancet, 1998
- CCR5-Δ32 gene deletion in HIV-1 infected patientsThe Lancet, 1997
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995